Browse Health
Orthopaedic Surgeon, Surgical Specialist
9 years of experience
Accepting new patients
Video profile


Education ?

Medical School Score Rankings
University of Pittsburgh (2002)
Top 25%

Awards & Distinctions ?

American Board of Orthopaedic Surgery
American Association of Hip and Knee Surgeons
American Society for Dermatologic Surgery

Affiliations ?

Dr. Vikoren is affiliated with 3 hospitals.

Hospital Affiliations



  • Massachusetts General Hospital
    Orthopaedic Surgery
    55 Fruit St, Boston, MA 02114
    Top 50%
  • Doylestown Hospital
    Orthopaedic Surgery
    595 W State St, Doylestown, PA 18901
    Top 50%
  • Mass General Hospital
  • Publications & Research

    Dr. Vikoren has contributed to 3 publications.
    Title From Clinical Pathways to Cpoe: Challenges and Opportunities in Standardization and Computerization of Postoperative Orders for Total Joint Replacement.
    Date March 2007
    Journal Journal of Surgical Orthopaedic Advances

    Clinical pathways, or caremaps, have become key tools for hospitals to streamline patient care. They are most applicable in situations where a high degree of predictability regarding treatment and/or diagnostic intervention is expected. Perceived advantages include cost savings, more uniform nursing care, and improved patient satisfaction. Total joint replacement is an ideal indication for implementation of clinical pathways. At the authors' institution, despite the adoption of a clinical pathway for these procedures, postoperative orders continue to be handwritten DE NOVO adding variability that may be detrimental to patient safety. This article describes the authoring and implementation of a computerized order process for the care of postoperative total joints patients using a multidisciplinary approach.

    Title Mechanical Evaluation of Bone Samples Following Alendronate Therapy in Healthy Male Dogs.
    Date April 2006
    Journal Journal of Biomedical Materials Research. Part B, Applied Biomaterials

    Alendronate and other bisphosphonates are clinically efficacious in treating postmenopausal osteoporosis, Paget's disease and hypercalcemia associated with malignancy. Because bisphosphonates are being considered for use in younger patients with joint replacements to prevent osteolysis, and for stress fracture prophylaxis in military recruits, it is important to know how bisphosphonate therapy affects healthy bone. We sought to determine whether bones from healthy male dogs exhibit alterations in structural or mechanical properties following alendronate treatment for 23 weeks. We tested trabecular tissue samples in compression and determined tissue ash density. We tested whole long bones in bending and torsion. For trabecular samples, we evaluated trabecular modulus, strength, and density. For whole bone specimens, we compared structural stiffness and ultimate load. We found no significant differences in any measure, between canines treated with alendronate for 23 weeks and controls, although we found consistent trends toward higher properties in the treated group. Correlation analysis revealed significant relationships between stiffness and strength measures for each mechanical test. Our results indicate bisphosphonate treatment in healthy canines does not weaken the properties of bone. The trends indicate a slight positive overall effect of alendronate treatment on the mechanical properties of healthy canine bone.

    Title Anticardiolipin Antibody Associated Arterial Thrombosis Following Fibula Fracture.
    Date July 2003
    Journal Foot & Ankle International / American Orthopaedic Foot and Ankle Society [and] Swiss Foot and Ankle Society

    A case is described of a 20-year-old college student in whom open reduction and internal fixation of a Weber B fibula fracture was complicated by arterial thrombosis and gangrene of the foot. The patient subsequently required a below-knee amputation. A hypercoagulability workup revealed the presence of an anticardiolipin antibody. Although this is an extremely unusual complication, young female patients with a positive personal or family history of early thrombotic events, such as DVT, multiple pregnancy loss, or early myocardial infarction, should be viewed as being at increased risk. Additional risk factors such as oral contraceptive use, should be sought during the initial history.

    Similar doctors nearby

    Dr. Robert Handy

    Orthopaedic Surgery
    22 years experience
    Doylestown, PA

    Dr. Charles Burrows

    Orthopaedic Surgery
    18 years experience
    Doylestown, PA

    Dr. Thomas Mackell

    Orthopaedic Surgery
    39 years experience
    Doylestown, PA

    Dr. Kieran Cody

    Orthopaedic Surgery
    Doylestown, PA

    Dr. Jung Park

    Orthopaedic Surgery
    Doylestown, PA

    Dr. Francis Boland

    Orthopaedic Surgery
    49 years experience
    Doylestown, PA
    Search All Similar Doctors